TY - JOUR
T1 - B-type lymphocytic leukaemia developing seven years after chemoradiotherapy for hodgkin's disease
T2 - Report of a case and review of the literature
AU - Yehuda, Arie Ben
AU - Okon, Eli
AU - Leizerowttz, Rachel
AU - Polliack, Aaron
PY - 1990
Y1 - 1990
N2 - This report describes the development of B-cell lymphocytic, leukemia, probably a leukaemic phase of non-Hodgkin's lymphoma, in a patient with Hodgkin's disease (HD) who was successfully treated and cured with MOPP combination chemotherapy and mantle radiotherapy. The leukaemia occurred seven years after the completion of chemoradiotherapy, and manifested as peripheral blood and bone-marrow involvement alone without any initial evidence of lymphadenopathy, organomegaly or extranodal disease at the time of diagnosis. The occurrence of B-lymphocytic leukaemia in a cured patient with HD is rare, and the association of these two disorders is reviewed and discussed in the light of current knowledge.
AB - This report describes the development of B-cell lymphocytic, leukemia, probably a leukaemic phase of non-Hodgkin's lymphoma, in a patient with Hodgkin's disease (HD) who was successfully treated and cured with MOPP combination chemotherapy and mantle radiotherapy. The leukaemia occurred seven years after the completion of chemoradiotherapy, and manifested as peripheral blood and bone-marrow involvement alone without any initial evidence of lymphadenopathy, organomegaly or extranodal disease at the time of diagnosis. The occurrence of B-lymphocytic leukaemia in a cured patient with HD is rare, and the association of these two disorders is reviewed and discussed in the light of current knowledge.
KW - B cells
KW - Chemoradiotherapy
KW - Hodgkin's disease
KW - Lymphocytic leukaemia
KW - Secondary leukaemia
UR - http://www.scopus.com/inward/record.url?scp=0025142380&partnerID=8YFLogxK
U2 - 10.3109/10428199009042489
DO - 10.3109/10428199009042489
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0025142380
SN - 1042-8194
VL - 1
SP - 265
EP - 269
JO - Leukemia and Lymphoma
JF - Leukemia and Lymphoma
IS - 3-4
ER -